These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23331355)

  • 1. Vaccination against hepatitis A and B in persons subject to homelessness in inner Sydney: vaccine acceptance, completion rates and immunogenicity.
    Poulos RG; Ferson MJ; Orr KJ; McCarthy MA; Botham SJ; Stern JM; Lucey A
    Aust N Z J Public Health; 2010 Apr; 34(2):130-5. PubMed ID: 23331355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre.
    Macdonald V; Dore GJ; Amin J; van Beek I
    Sex Health; 2007 Mar; 4(1):27-30. PubMed ID: 17382034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults.
    Nyamathi A; Liu Y; Marfisee M; Shoptaw S; Gregerson P; Saab S; Leake B; Tyler D; Gelberg L
    Nurs Res; 2009; 58(1):13-22. PubMed ID: 19092551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.
    Collier MG; Drobeniuc J; Cuevas-Mota J; Garfein RS; Kamili S; Teshale EH
    Vaccine; 2015 Jun; 33(24):2808-12. PubMed ID: 25889161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The immunological effectiveness and reactogenicity of the vaccine "HEP-A+B-in-VAC" against hepatitis A and B].
    Chuĭkova KI; Gordetskaia EL; Gorbunov MA; Maĭdaniuk AG; Pomytkina MI
    Vopr Virusol; 2006; 51(1):31-3. PubMed ID: 16515040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
    Shapiro AJ; Esther CR; Leigh MW; Dellon EP
    Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to hepatitis A and B vaccination in patients with chronic hepatitis C: 8-year follow-up.
    Kalyoncu D; Urganci N
    Paediatr Int Child Health; 2012 Aug; 32(3):136-9. PubMed ID: 22824660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and seroprevalence of markers for hepatitis A, B and C in persons subject to homelessness in inner Sydney.
    Poulos R; Ferson M; Orr K; Lucy A; Botham S; McCarthy M; Stern J; Dixon J; Murray C; Polis S
    Aust N Z J Public Health; 2007 Jun; 31(3):247-51. PubMed ID: 17679243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of a hepatitis B vaccination program for clients of a drug consumption facility.
    Scherbaum N; Timm J; Richter F; Bonnet U; Bombeck J; Lajos S; Specka M
    J Clin Virol; 2018 Sep; 106():28-32. PubMed ID: 30015286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the immunogenicity of combined hepatitis A and B vaccine by a prospective and retrospective trial.
    Wolters B; Müller T; Ross RS; Clauberg R; Werfel U; Roggendorf H; Siggelkow C; Hausen T; Roggendorf M
    Hum Vaccin; 2009 Apr; 5(4):248-53. PubMed ID: 19276678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of completing an accelerated vaccine series for homeless adults.
    Nyamathi AM; Sinha K; Saab S; Marfisee M; Greengold B; Leake B; Tyler D
    J Viral Hepat; 2009 Sep; 16(9):666-73. PubMed ID: 19245384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
    Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
    Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic.
    Ramasamy P; Lintzeris N; Sutton Y; Taylor H; Day CA; Haber PS
    Addiction; 2010 Feb; 105(2):329-34. PubMed ID: 20078489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.